Johnson & Johnson’s Kovid vaccine in India will be made by Biological E Ltd.
New Delhi:
Union Health Minister Mansukh Mandaviya tweeted, US pharmaceutical giant Johnson & Johnson’s single-dose COVID-19 vaccine has received emergency use approval in India.
He tweeted on Saturday afternoon, “India expands its vaccine basket! Johnson & Johnson’s single-dose COVID-19 vaccine has been approved for emergency use in India. India now has 5 EUA vaccines. The collective fight of the country will get further impetus.”
The shot will be brought to India through a supply agreement with domestic vaccine maker Biological E Ltd.
The healthcare major got India’s approval for its vaccine a day after applying for an emergency use authorization (EUA). Biologicals E will be an important part of Johnson & Johnson’s global supply chain network, which is developing its COVID-19 vaccine Janssen through broad collaboration and partnerships with governments, health officials and organizations such as Gavi and the COVAX facility, the company said on Friday. supply will help. .
Along with this, India has five vaccines of Kovid, which have been approved for emergency use. The other four are Serum Institute’s Kovishield, Bharat Biotech’s Kovaxin, Russia’s Sputnik V and Moderna.
.